Lanostane Derivatives for Cancer Cachexia Muscle Preservation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cachexia, particularly in cancer patients, are ineffective in preventing or reversing muscle wasting and weight loss, often resulting in temporary weight gain without muscle mass increase and are associated with adverse side effects.
Innovation Solution
A pharmaceutical composition containing a lanostane compound derived from Poria extract, which is administered orally and formulated with nutrients like glucose, amino acids, and vitamins to treat cachexia and anorexia, using a process involving extraction and purification methods such as silica gel column chromatography.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Weight of moving object
If hormonal appetite enhancer (such as megestrol, medroxyprogesterone acetate) is used to treat cachexia, then body weight increases temporarily, but muscle mass does not increase and adverse side effects occur
Solution Approach 1:
The patent changes the chemical parameter from synthetic hormonal compounds to natural lanostane derivatives, fundamentally altering the substance class and its interaction with the body's metabolic system, thereby achieving weight maintenance without the adverse effects associated with hormonal agents
Solution Approach 2:
The patent employs natural compounds with shorter half-lives and more favorable pharmacokinetic profiles compared to long-acting hormonal agents, allowing for more controlled and less persistent physiological effects that avoid accumulation of harmful side effects
2Weight of moving object
If hormonal appetite enhancer is used to treat cachexia, then body weight increases, but there is no increase of body muscle
Solution Approach 1:
The patent shifts from hormonal mechanisms that primarily affect adipose tissue to lanostane derivatives that influence protein synthesis and muscle metabolism, fundamentally changing the physiological pathway to achieve both weight and muscle preservation
Solution Approach 2:
The lanostane derivatives act as intermediary substances that modulate multiple metabolic pathways simultaneously, including protein synthesis, fat metabolism, and energy expenditure, thereby achieving coordinated effects on both muscle mass and body weight
3Quantity of substance
If food amount is increased to treat cachexia, then nutrient intake improves, but weight loss continues to occur
Solution Approach 1:
The patent introduces a feedback mechanism through lanostane derivatives that regulate metabolic rate and protein catabolism, creating a balance where increased nutrient intake is effectively utilized to prevent weight loss rather than being wasted through increased catabolic activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively stabilizes body weight and improves nutritional status in cancer patients by enhancing appetite and muscle maintenance, reducing side effects and improving overall health and survival prognosis.
Implementation Method 1
enhancing appetite and muscle maintenance
Implementation Method 2
increase of body muscle
Implementation Method 3
Poria extract and lanostanes purified therefrom show an inhibition effect on immunity
Implementation Method 4
Poria extract and lanostanes purified therefrom have an effect on human intestines and enhance the uptake of nutrients: absorption of glucose, amino acids, and vitamins
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
A pharmaceutical composition for treating cachexia, and in particular for treating cancer cachexia. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.